Ares Financial Consulting
RMD icon

Ares Financial Consulting’s ResMed RMD Stock Holding History

Ares Financial Consulting’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.74K Hold
35
– – 0.01% 616
2026
Q2 		$6.82K Hold
35
– – ﹤0.01% 647
2026
Q1 		$7.8K Hold
35
– – 0.01% 600
2025
Q4 		$8.43K Buy
+35
New +$8.95K 0.01% 383

Other funds holding RMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Ares Financial Consulting's RMD Position: Q3 2026 in Review

Ares Financial Consulting held its ResMed (RMD) position steady in Q3 2026 at 35 shares worth $7.74K. The position accounts for 0.01% of the portfolio, ranked #616.

Ares Financial Consulting first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $8.43K in Q4 2025. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Ares Financial Consulting held 35 shares of ResMed worth $7.74K as of Q3 2026.
  • Ares Financial Consulting left its ResMed share count unchanged in Q3 2026.
  • ResMed made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #616 holding.
  • Ares Financial Consulting first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's ResMed position peaked at $8.43K in Q4 2025.
  • 535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.